Summit Therapeutics reached a milestone in its Phase III trial for ivonescimab, aiming to treat second-line EGFR mutated advanced NSCLC. The FDA has fast tracked the HARMONi trial. Positive ...
The Patient Recruitment for Rare Disease Trials Summit addresses these obstacles head-on by exploring innovative strategies to identify and engage eligible participants more efficiently.
SUMMIT COUNTY, Ohio (WOIO) - The 24-year-old Akron daughter found guilty of killing her mom could soon be granted a second trial after the Ninth District Court of Appeals overturned her conviction ...